RAPTOR PHARMACT (RPTP)
(Delayed Data from NSDQ)
$9.00 USD
0.00 (0.00%)
Updated Oct 24, 2016 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[RPTP]
Reports for Purchase
Showing records 1 - 20 ( 83 total )
Industry: Medical - Biomedical and Genetics
Horizon to Acquire RPTP, Deal Looks Expensive in Our View, Reiterate NEUTRAL and Raising PT to $9
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
Sales Beat in 2Q and FY16 Rev Guidance Raised, but We Continue to See Modest Long-Term Growth Potential, Reiterate N
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
1Q16 Results; Procysbi Sales In-line; Quinsair Sales Begin in EU, We See Slow Uptake, Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
RPTP Seeks Sale--We See a Takeout as Unlikely, Reiterate NEUTRAL Rating
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
4Q15 Results and 2016 Outlook, Adjusting our Pricing and Market Size Estimates for Quinsair Down, Reiterate N and Lowering PT to $4 (from $7).
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of Feb. 1This report contains brief updates on the following: SRPT, RGLS, BMRN, CBYL, CLDX, EPRS, LXRX, PCRX, PRTA, PTCT, RPTP, TTPH, RARE, VTAE, ICPT, CERU, FCSC, GBT, TSRO, TRVN, IRWD, MRTX, DNAI, XNCR. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of Jan. 11th
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
Long-Term Huntington''s Data Fails to Resolve Key Concerns with RP103, We See Ph 3 as High-Risk and Expensive, Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of Nov. 23
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Upgrading to NEUTRAL (from UNDERPERFORM) Based on Valuation, but Remaining Negatively Biased on Huntington''s Program; RPTP 3Q Results
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of Nov. 2This report contains brief updates on the following: DYAX, ANAC, IRWD, ECYT, FATE, XNCR, RGLS, MGNX, FCSC, SNSS, INFI, MDVN, RPTP, SRPT, XOMA, AGTC, EPZM, BLUE, PTCT, CATB, EPRS, ABUS, ICPT. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of October 5
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Industry: Medical - Biomedical and Genetics
As Expected, RP103 Disappoints in NASH, Reiterate UNDERPERFORM and $7 Price Target
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
As Expected, RP103 Disappoints in NASH, Reiterate UNDERPERFORM and $7 Price Target
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of September 14thThis report contains brief updates on the following: BIOD, CDTX, SGMO, EPZM, LXRX, NVAX, RPTP. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Industry: Medical - Biomedical and Genetics
Acquire Quinsair; Plans EU and Canada Launch 1H16; Raising PT to $7 but Reiterate UNDERPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of August 24
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of August 17
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Industry: Medical - Biomedical and Genetics
2Q15 Earnings, Pediatric NASH Data Expected This Quarter, Reiterate UNDERPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D